FDA Investigator Guozhou Mo
Guozhou Mo has conducted inspections on 13 sites in 3 countries as of 08 Sep 2023. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
13
Last Inspection Date:
08 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America,
Taiwan,
China
FDA Investigators that have inspected at least one site in common with Guozhou Mo:
Abby E Pelletier,
Andre S Lamontagne,
Darin S Wiegers,
David P Vanhouten,
Emir Galevi,
George T Allen, Jr,
James W Whitney,
John A Hamilton, III,
Justina O Tam,
Justine M Corson,
Kayla R Huffman,
Lauren M Lawrance,
Lauren M Mclaughlin,
Lisa D Cash,
Michael P Sweeney,
Nabil Nakhoul,
Nassim Ben Makhlouf,
Paul P Geraci,
Sandra P White,
Seth A Mailhot,
Stephen C Smith,
Terry C Kimball
Guozhou Mo's Documents
Publish Date | Document Type | Title |
---|---|---|
January, 2023 | FDA 483 | Candela Corporation - Form 483, 2023-01-24 |
October, 2021 | FDA 483 | Medtronic Vascular, Inc. - Form 483, 2021-10-15 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more